Patents

US 12662482 B2: Compounds which inhibit RNA polymerase

Granted
2026-06-23
Filed
2021-09-15 application 18024417
Type
Utility · 21 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that inhibit RNA polymerase I (Pol I). Said chemical entities are useful, e.g., for treating a condition, disease or disorder in which increased (e.g., excessive) Pol I activity contributes to the pathology and/or symptoms and/or progression of the condition, disease or disorder (e.g., cancer) in a subject (e.g., a human). This disclosure also features compositions containing the same as well as methods of using and making the same.

Source: PTBLXML, file of 2026-06-23 (ipgb20260623.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
The Johns Hopkins University 2,182 patentsUS company or organizationBaltimore, MDJohns Hopkins University College or university FUZZY medium confidence: same name (governing-board words and legal endings aside) and statePTBLXML, file of 2026-06-23
Lieber Institute, Inc. 9 patentsUS company or organizationBaltimore, MDLIEBER INSTITUTE INC Nonprofit EXACT high confidence: identical full name and statePTBLXML, file of 2026-06-23

Inventors

InventorPlacePatentsPerson pageSource
Hester Hui LiuCockeysville, MD2PTBLXML, file of 2026-06-23
James C. BarrowArnold, MD29PTBLXML, file of 2026-06-23
Marikki K. LaihoKauniainen, FIPTBLXML, file of 2026-06-23
Rajesh Kumar NvBaltimore, MDPTBLXML, file of 2026-06-23
Pablo de LeonBaltimore, MD7PTBLXML, file of 2026-06-23
Tony DoradoBaltimore, MDPTBLXML, file of 2026-06-23
Asma BegumBaltimore, MDPTBLXML, file of 2026-06-23
Wenjun FanBaltimore, MDPTBLXML, file of 2026-06-23
Gregory StachelekBaltimore, MDPTBLXML, file of 2026-06-23

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D471/04PTBLXML, file of 2026-06-23

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2024-03-07Assignment
Assignment of assignor's interest
BARROW, JAMES C. signed 2021-09-09
DE LEON, PABLO signed 2021-09-09
LIEBER INSTITUTE, INC. BALTIMORE, MD66688/214PASDL, file of 2026-10-15
2024-03-07Assignment
Assignment of assignor's interest
LIU, HESTER HUI signed 2021-09-10
LAIHO, MARIKKI K. signed 2021-09-09
NV, RAJESH KUMAR signed 2021-09-09
DORADO, TONY signed 2021-09-09
BEGUM, ASMA signed 2021-09-09
FAN, WENJUN signed 2021-09-09
STACHELEK, GREGORY signed 2021-09-10
THE JOHNS HOPKINS UNIVERSITY BALTIMORE, MD66688/146PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.